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Abstract
Background: Granulicatella and Abiotrophia spp. are difficult to detect due to their complex nutritional requirements.
Infections with these organisms are associated with high treatment failure rates. We report the first implant-associated
infection caused by Granulicatella para-adiacens, which was cured with anti-microbial treatment consisting of
anti-biofilm-active rifampin and debridement, exchange of mobile parts and retention of the prosthesis.
Case presentation: Patient with a history of left hip arthroplasty presented with acute onset of fever, pain
and limited range of motion of the left hip. Arthrocentesis of the affected joint yielded purulent fluid and
exchange of mobile parts of the prosthesis, but retention of fixed components was performed. Granulicatella
para-adiacens grew from preoperative and intraoperative cultures, including sonication fluid of the removed
implant. The transesophageal echocardiography showed a vegetation on the mitral valve; the orthopantogram
demonstrated a periapical dental abscess. The patient was treated with intravenous penicillin G and gentamicin for
4 weeks, followed by levofloxacin and rifampin for additional 2 months. At discharge and at follow-up 1, 2 and 5 years
later, the patient was noted to have a functional, pain-free, and radiologically stable hip prosthesis and the
serum C-reactive protein was normal.
Conclusions: Although considered a difficult-to-treat organism, we report a successful treatment of the Granulicatella
hip prosthesis infection with prosthesis retention and a prolonged antibiofilm therapy including rifampin. The
periapical dental abscess is considered the primary focus of hematogenously infected hip prosthesis, underlining the
importance treatment of periodontitis prior to arthroplasty and of proper oral hygiene for prevention of
hematogenous infection after arthroplasty.
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Background
The genera Granulicatella and Abiotrophia, formerly
known as “nutritionally variant streptococci” (NVS) are
part of normal oral, urogenital and intestinal flora in
humans [1, 2]. They are rarely reported as human
pathogens. They can cause infective endocarditis,
comprising 4.3-6 % of endocarditis and other endovascular
infections [3–7], meningitis, osteoarticular infections,
endophthalmitis, keratitis and chronic sinusitis [8–11].
Due to common treatment failure in endocarditis and
osteoarticular infection, NVS are considered difficult-
to-treat organisms with frequent treatment failures
[12–14]. Particularly in infective endocarditis relapse
rates up to 41 % were reported [2, 3, 15]. Among
implant-associated infections, only five cases of peri-
prosthetic joint infections with Granulicatella or
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infection with Granulicatella adiacens have been de-
scribed [20].
Since the first description of NVS by Frenkel and
Hirsch in 1961 when isolated from a patient with infect-
ive endocarditis and otitis media [21], the terminology of
NVS has changed several times. The species Abiotrophia
para-adiacens was proposed on the basis of 16sRNA
analysis [22]. Finally, reclassification of Abiotrophia
adiacens, balaenopterae and elegans to a new genus
Granulicatella was proposed in 2000 [23]. These gram-
positive cocci or coccobacilli are nutritionally deficient,
slow-growing and fastidious, expressing better growth
around colonies of other bacteria, a microbiological
phenomenon known as satellitism [14, 24]. They require
blood or hemoglobin, amino acids and some vitamins
to grow. These complex nutritional requirements
make their detection often difficult. Because of their
unique culture requirements and pleomorphic pheno-
typic features, misidentification or nonidentification
by using commercially available phenotypic testing
occur, prompting the recommendation that 16S rRNA
gene sequencing be used for species-level identification of
NVS infections. The Clinical and Laboratory Standards
Institute (CLSI) does not recommend disk diffusion test-
ing to determine the antimicrobial susceptibility of NVS
and suggests broth microdilution MIC (minimal inhibitory
concentration) testing in cation-adjusted Mueller-Hinton
broth with 2.5 %–5 % lysed horse blood and 0.001 % pyri-
doxine hydrochloride [25].
The optimal antimicrobial treatment of NVS is not
defined, especially data on implant-associated infec-
tions are scarce [12, 16–20]. In vitro antimicrobial
drug susceptibility patterns do not correlate well with
clinical response to treatment, and infections with
NVS often respond poorly to antimicrobial treatment.
Higher rates of microbiological failure and relapse
rates after treatment have been observed for infection
with NVS than with streptococci and related genera
[2, 3, 12, 13, 15]. No experimental data are available
regarding the activity of rifampin against Granulicatella
or Abiotrophia spp. biofilms. Nevertheless, rifampin was
used in several cases including infection of the breast im-
plant [20], cardiac pacemaker and vertebral osteomyelitis
[26] and knee periprosthetic joint infection [12]. No resist-
ance to rifampin has been reported in NVS [24].
Case presentation
A 65-years-old man was admitted to hospital with a 3-day
history of acute left hip pain accompanied by fever, chills
and malaise. A non-cemented metal-on-metal hip
prosthesis was implanted on the left side after a trau-
matic fracture 7 years ago. The postoperative course
after arthroplasty was unremarkable and the joint
function was satisfactory until the recent event. At
admission, the patient was febrile (38.7 °C), complaining
about hip pain at mobilization with a limited range of mo-
tion. No redness, swelling, warmth or sinus tract was ob-
served. A severe periodontitis was noticed by oral
examination. Heart and lung auscultation was normal, ab-
dominal examination was unremarkable, no skin or muco-
sal abnormalities were observed. At admission leukocyte
count was 8.5 G/L (normal 4-10 G/L), platelet count
190 G/L (normal 150-300 G/L) and creatinine 96 mmol/L
(normal 62-106 mmol/L). Liver transaminases were nor-
mal, serum C-reactive protein was 262 mg/L (normal
<10 mg/L) and rheumatoid factor was negative (11 U/mL,
normal <20 U/mL). Ultrasonography of the left hip
showed joint effusion and 4 mL of purulent synovial fluid
was aspirated. The synovial leukocyte count was 12,500
cells/μL with 92 % granulocytes. No microorganisms were
seen in the Gram stain.
Conventional hip x-ray showed no signs of prosthesis
loosening (Fig. 1). A revision hip surgery was performed
on the day after admission with exchange of mobile
parts (polyethylene part and head of the prosthesis) and
extensive débridement, but retention of the femoral and
Fig. 1 Preoperative conventional x-ray of the hip prosthesis, imaging
with intra-articular contrast medium injection (arrow)
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acetabular prosthesis components. Removed mobile
parts were sent for microbiological investigation for
adherent biofilms by sonication. During surgery, puru-
lent fluid was discharged after opening the joint cap-
sule. Empiric treatment with intravenous amoxicillin/
clavulanic acid (2.2 g every 8 h) was initiated.
Synovial fluid aspirate, periprosthetic tissue and sonic-
ation fluid were cultured aerobically and anaerobically
for 14 days. A microorganism subsequently identified as
Granulicatella para-adiacens grew from the sonication
fluid on day 3 (>1000 colony-forming units/mL fluid),
from the hip aspirate on day 9 and from one of three in-
traoperatively collected periprosthetic tissue samples on
day 10. Blood cultures remained negative during 14 days
of incubation. The identification of Granulicatella spp.
was performed by biochemical tests and sequencing de-
termination based on the 16S rRNA technology [27].
The minimal inhibitory concentration (MIC), performed
by E-test (AB Biodisk, Solna, Sweden), was 0.19 mg/l for
benzylpenicillin, 1 mg/L for ceftriaxone, 0.002 mg/L for
rifampin and 0.25 mg/L for levofloxacin. According to
CLSI interpretive criteria [25], the Granulicatella
para-adiacens isolate was intermediate susceptible to
penicillin (susceptible at MIC ≤0.12 mg/L), just below
the susceptible breakpoint of ceftriaxone (susceptible
at MIC ≤1 mg/L). No interpretive criteria are estab-
lished by the CLSI for levofloxacin and rifampin, but
the MIC values were low.
The empiric therapy was modified on day 3 to
intravenous benzylpenicillin (5 million units every
6 h) plus gentamicin (80 mg every 8 h) for 4 weeks.
Transesophageal echocardiography demonstrated a
non-mobile vegetation on the posterior leaflet of the
mitral valve (size 4 x 6 mm). Transesophageal echo-
cardiography was repeated 4 weeks later and the size
of the vegetation remained unchanged. In the ortho-
pantogram, 15 missing teeth and a periapical dental
abscess of tooth No. 12 was noticed (Fig. 2). Tooth
extraction was performed during the intravenous anti-
biotic therapy.
At discharge, after completing 4 weeks of intravenous
antibiotic treatment, the patient was fully mobilized, re-
ported no pain in the hip and had a normal C-reactive
protein value (3 mg/L). Treatment was continued with
oral levofloxacin (500 mg every 12 h) plus rifampin
(450 mg every 12 h) for additional 2 months to complete
the 3 month treatment course. At follow-up visits at 1, 2
and 5 years after revision surgery, the patient presented
with a functional, pain-free and radiologically stable hip
prosthesis without local signs of infection and with
normal serum C-reactive protein. Figure 3 shows the
hip x-ray 5 years after surgery.
Discussion
We present a case of hematogenous infection of hip
prosthesis caused by Granulicatella para-adiacens oc-
curring 7 years after primary arthroplasty. The infection
manifested acutely with fever and discrete local symp-
toms (joint pain at mobilization and limited range of
motion). The most likely origin of the periprosthetic
Fig. 2 Orthopantogram at hospital admission showing severe
periodontitis and periapical abscess of tooth Nr. 12 (arrow). The
dental abscess is the most likely origin of hematogenous seeding of
Granulicatella spp. to the hip prosthesis. An extraction of the tooth was
performed during intravenous antibiotic treatment
Fig. 3 Native x-ray of the hip prosthesis 5 years after surgery. No
signs of loosening or migration are visible
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infection was the periapical dental abscess or severe
periodontitis. According to modified Duke criteria
[28], possible infective endocarditis was diagnosed
based on one major criterion (mitral valve vegetation)
and two minor criteria: fever and hematogenous seed-
ing of the hip prosthesis. Granulicatella is often asso-
ciated with endocarditis exhibiting affinity to the
avascular cordae [29].
Interestingly, Granulicatella para-adiacens grew first
from the sonication fluid (day 3), followed by the pre-
operatively aspirated synovial fluid (day 9) and peripros-
thetic tissue specimens (day 10), indicating the highest
density of bacteria on the implant surface [30]. Only one
of three periprosthetic tissues grew Granulicatella para-
adiacens despite presence of visible pus, indicating the
importance of sampling several (at least three) peripros-
thetic tissue specimens during surgery.
To our knowledge, this is the first case of successfully
treated implant-associated infection caused by NVS
without removal of the fixed components of the hip im-
plant. All previously published cases were treated with a
two-stage surgical approach, including an implant-free
interval of at least four weeks [12, 17, 19]. In our patient,
an acute hematogenous periprosthetic joint infection
with an immature biofilm (<3 weeks of age) was diag-
nosed and only mobile components were exchanged ac-
cording to current recommendation [31]. After initial
intravenous combination of penicillin and gentamicin
for 4 weeks (also sufficient for the treatment of possible
infective endocarditis), an oral combination therapy with
rifampin and levofloxacin was continued in order to
eradicate the biofilm on the remaining foreign body.
This case report is illustrative for several reasons.
First, it underlines the importance of carrying out
proper preoperative and intraoperative procedures
(preoperative joint puncture, multiple intraoperative
periprosthetic tissue samples, sonication of removed
implant parts) to diagnose prosthetic joint infections.
Sonication of removed prosthetic parts is particularly
useful for rapid and improved microbiological diagno-
sis, especially when low-burden and patchy distribu-
tion of microbial biofilms are expected [30]. Second,
joint infections due to NVS occurring after dental
work are well described in the literature [17, 32],
which underlines the importance of the treatment of
periodontitis before implantation of a prosthesis and
proper oral hygiene after arthroplasty for primary and
secondary prevention of prosthetic joint infection.
Third, the NVS may not be needed to be classified as
a difficult-to-treat-organism, if exchange of the mobile
parts is followed by antimicrobial therapy that also
includes biofilm-effective antibiotics such as rifampin.
Current guidelines recommend for infective endocarditis
due to Granulicatella a treatment with antibiotics that are
used for treatment of infective endocarditis due to strepto-
cocci with intermediate susceptibility to penicillin (com-
bination of penicillins or ceftriaxon or vancomycin 4-6
weeks and gentamicin 2 weeks) [33]. In our case, we per-
formed the combined intravenous treatment for 4 weeks
taking in account the difficult-to-treat-character of Granu-
licatella and completed the recommended 12 weeks
course of antibiotic therapy for periprosthetic joint infec-
tions with streptococci with a combination of levofloxacin
and rifampin.
Conclusion
Although Granulicatella is considered a difficult-to-
treat bacterial organism, we report successful treatment
of a Granulicatella hip prosthesis infection and possible
infective endocarditis with exchange of mobile parts,
debridement and prosthesis retention and a prolonged
course of antimicrobial therapy including biofilm-
effective antibiotics. The periapical dental abscess is
considered the primary focus of hematogenously
infected hip prosthesis, underlining the importance
treatment of periodontitis prior to arthroplasty and of
proper oral hygiene for prevention of hematogenous in-
fection after arthroplasty.
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